BACKGROUND: Since 2010, nationwide networks of reference centers for sarcomas (RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases of sarcomas and connective tumors of intermediate malignancy (TIM) in France. METHODS: The nationwide incidence of sarcoma or TIM (2013-2016) was measured using the 2013 WHO classification and confirmed by a second independent review by expert pathologists. Simple clinical characteristics, yearly variations and correlation of incidence with published clinical trials are presented and analyzed. RESULTS: Over 150 different histological subtypes are reported from the 25172 patients with sarcomas (n = 18712, 74,3%) or TIM (n = 6460, 25.7%), with n = 5838, n = 6153, n = 6654, and n = 6527 yearly cases from 2013 to 2016. Over these 4 years, the yearly incidence of sarcomas and TIM was therefore 70.7 and 24.4 respectively, with a combined incidence of 95.1/106/year, higher than previously reported. GIST, liposarcoma, leiomyosarcomas, undifferentiated sarcomas represented 13%, 13%, 11% and 11% of tumors. Only GIST, as a single entity had a yearly incidence above 10/106/year. There were respectively 30, 64 and 66 different histological subtypes of sarcomas or TIM with an incidence ranging from 10 to 1/106, 1-0.1/106, or < 0.1/106/year respectively. The 2 latter incidence groups represented 21% of the patients with 130 histotypes. Published phase III and phase II clinical trials (p<10-6) are significantly higher with sarcomas subtypes with an incidence above 1/106 per. CONCLUSIONS: This nationwide registry of sarcoma patients, with exhaustive histology review by sarcoma experts, shows that the incidence of sarcoma and TIM is higher than reported, and that tumors with a very low incidence (1<106/year) are less likely to be included in clinical trials.
BACKGROUND: Since 2010, nationwide networks of reference centers for sarcomas (RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases of sarcomas and connective tumors of intermediate malignancy (TIM) in France. METHODS: The nationwide incidence of sarcoma or TIM (2013-2016) was measured using the 2013 WHO classification and confirmed by a second independent review by expert pathologists. Simple clinical characteristics, yearly variations and correlation of incidence with published clinical trials are presented and analyzed. RESULTS: Over 150 different histological subtypes are reported from the 25172 patients with sarcomas (n = 18712, 74,3%) or TIM (n = 6460, 25.7%), with n = 5838, n = 6153, n = 6654, and n = 6527 yearly cases from 2013 to 2016. Over these 4 years, the yearly incidence of sarcomas and TIM was therefore 70.7 and 24.4 respectively, with a combined incidence of 95.1/106/year, higher than previously reported. GIST, liposarcoma, leiomyosarcomas, undifferentiated sarcomas represented 13%, 13%, 11% and 11% of tumors. Only GIST, as a single entity had a yearly incidence above 10/106/year. There were respectively 30, 64 and 66 different histological subtypes of sarcomas or TIM with an incidence ranging from 10 to 1/106, 1-0.1/106, or < 0.1/106/year respectively. The 2 latter incidence groups represented 21% of the patients with 130 histotypes. Published phase III and phase II clinical trials (p<10-6) are significantly higher with sarcomas subtypes with an incidence above 1/106 per. CONCLUSIONS: This nationwide registry of sarcomapatients, with exhaustive histology review by sarcoma experts, shows that the incidence of sarcoma and TIM is higher than reported, and that tumors with a very low incidence (1<106/year) are less likely to be included in clinical trials.
Authors: Gemma Gatta; Jan Maarten van der Zwan; Paolo G Casali; Sabine Siesling; Angelo Paolo Dei Tos; Ian Kunkler; Renée Otter; Lisa Licitra; Sandra Mallone; Andrea Tavilla; Annalisa Trama; Riccardo Capocaccia Journal: Eur J Cancer Date: 2011-10-25 Impact factor: 9.162
Authors: Roberta Sanfilippo; Robin L Jones; Jean-Yves Blay; Axel Le Cesne; Salvatore Provenzano; Georgios Antoniou; Olivier Mir; Giovanni Fucà; Elena Fumagalli; Rossella Bertulli; Silvia Stacchiotti; Mehdi Brahmi; Federica Grosso; Armelle Dufresne; Nadia Hindi; Marta Sbaraglia; Alessandro Gronchi; Paola Collini; Angelo P Dei Tos; Paolo G Casali Journal: Clin Cancer Res Date: 2019-06-19 Impact factor: 12.531
Authors: Margaret von Mehren; R Lor Randall; Robert S Benjamin; Sarah Boles; Marilyn M Bui; Ernest U Conrad; Kristen N Ganjoo; Suzanne George; Ricardo J Gonzalez; Martin J Heslin; John M Kane; Henry Koon; Joel Mayerson; Martin McCarter; Sean V McGarry; Christian Meyer; Richard J O'Donnell; Alberto S Pappo; I Benjamin Paz; Ivy A Petersen; John D Pfeifer; Richard F Riedel; Scott Schuetze; Karen D Schupak; Herbert S Schwartz; William D Tap; Jeffrey D Wayne; Mary Anne Bergman; Jillian Scavone Journal: J Natl Compr Canc Netw Date: 2016-06 Impact factor: 11.908
Authors: Attila Kollár; Christian Rothermundt; Frank Klenke; Beata Bode; Daniel Baumhoer; Volker Arndt; Anita Feller Journal: Cancer Epidemiol Date: 2019-09-11 Impact factor: 2.984
Authors: Anna Maria Frezza; Tarek Assi; Salvatore Lo Vullo; Eytan Ben-Ami; Armelle Dufresne; Kan Yonemori; Emi Noguchi; Brittany Siontis; Richard Ferraro; Pawel Teterycz; Florence Duffaud; Vinod Ravi; Bruno Vincenzi; Hans Gelderblom; Maria A Pantaleo; Giacomo G Baldi; Ingrid Desar; Alexander Fedenko; Robert G Maki; Robin L Jones; Robert S Benjamin; Jean Yves Blay; Akira Kawai; Mrinal Gounder; Alessandro Gronchi; Axel Le Cesne; Olivier Mir; Anna M Czarnecka; Scott Schuetze; Andrew J Wagner; Julien Adam; Marta Barisella; Marta Sbaraglia; Jason L Hornick; Alexandra Meurgey; Luigi Mariani; Paolo G Casali; Katherine Thornton; Silvia Stacchiotti Journal: Cancer Date: 2019-09-19 Impact factor: 6.921
Authors: Clement Trovik; Henrik C F Bauer; Emelie Styring; Kirsten Sundby Hall; Fredrik Vult Von Steyern; Sigvard Eriksson; Ingela Johansson; Mika Sampo; Minna Laitinen; Anders Kalén; Halldór Jónsson; Nina Jebsen; Mikael Eriksson; Erkki Tukiainen; Najme Wall; Olga Zaikova; Helgi Sigurðsson; Tuula Lehtinen; Bodil Bjerkehagen; Mikael Skorpil; Geir Egil Eide; Elisabeth Johansson; Thor A Alvegard Journal: Acta Orthop Date: 2017-03-07 Impact factor: 3.717
Authors: J-Y Blay; P Soibinet; N Penel; E Bompas; F Duffaud; E Stoeckle; O Mir; J Adam; C Chevreau; S Bonvalot; M Rios; P Kerbrat; D Cupissol; P Anract; F Gouin; J-E Kurtz; C Lebbe; N Isambert; F Bertucci; M Toumonde; A Thyss; S Piperno-Neumann; P Dubray-Longeras; P Meeus; F Ducimetière; A Giraud; J-M Coindre; I Ray-Coquard; A Italiano; A Le Cesne Journal: Ann Oncol Date: 2017-11-01 Impact factor: 32.976
Authors: Florencia Cidre-Aranaz; Sarah Watson; James F Amatruda; Takuro Nakamura; Olivier Delattre; Enrique de Alava; Uta Dirksen; Thomas G P Grünewald Journal: Nat Rev Dis Primers Date: 2022-10-06 Impact factor: 65.038
Authors: Tatiana Georgiesh; Ninna Aggerholm-Pedersen; Patrick Schöffski; Yifan Zhang; Andrea Napolitano; Judith V M G Bovée; Åse Hjelle; Gordon Tang; Mateusz Spalek; Margherita Nannini; David Swanson; Thomas Baad-Hansen; Raf Sciot; Asle C Hesla; Paul Huang; Desiree Dorleijn; Hans Kristian Haugland; Maribel Lacambra; Jacek Skoczylas; Maria A Pantaleo; Rick L Haas; Leonardo A Meza-Zepeda; Florian Haller; Anna M Czarnecka; Herbert Loong; Nina L Jebsen; Michiel van de Sande; Robin L Jones; Felix Haglund; Iris Timmermans; Akmal Safwat; Bodil Bjerkehagen; Kjetil Boye Journal: Br J Cancer Date: 2022-08-27 Impact factor: 9.075
Authors: Silvia Stacchiotti; Anna Maria Frezza; Jean-Yves Blay; Elizabeth H Baldini; Sylvie Bonvalot; Judith V M G Bovée; Dario Callegaro; Paolo G Casali; RuRu Chun-Ju Chiang; George D Demetri; Elisabeth G Demicco; Jayesh Desai; Mikael Eriksson; Hans Gelderblom; Suzanne George; Mrinal M Gounder; Alessandro Gronchi; Abha Gupta; Rick L Haas; Andrea Hayes-Jardon; Peter Hohenberger; Kevin B Jones; Robin L Jones; Bernd Kasper; Akira Kawai; David G Kirsch; Eugene S Kleinerman; Axel Le Cesne; Jiwon Lim; María Dolores Chirlaque López; Roberta Maestro; Rafael Marcos-Gragera; Javier Martin Broto; Tomohiro Matsuda; Olivier Mir; Shreyaskumar R Patel; Chandrajit P Raut; Albiruni R A Razak; Damon R Reed; Piotr Rutkowski; Roberta G Sanfilippo; Marta Sbaraglia; Inga-Marie Schaefer; Dirk C Strauss; Kirsten Sundby Hall; William D Tap; David M Thomas; Winette T A van der Graaf; Winan J van Houdt; Otto Visser; Margaret von Mehren; Andrew J Wagner; Breelyn A Wilky; Young-Joo Won; Christopher D M Fletcher; Angelo P Dei Tos; Annalisa Trama Journal: Cancer Date: 2021-04-28 Impact factor: 6.860
Authors: J-Y Blay; P Casali; C Bouvier; C Dehais; I Galloway; J Gietema; J Halámková; N Hindi; A Idbaih; E Kinloch; H-J Klümpen; T Kolarova; K Kopeckova; J Lovey; M Magalhaes; K Oselin; S Piperno-Neumann; A Ravnsbaek; M Rogasik; A Safwat; S Scheipl; M Seckl; J Taylor; M Temnyk; A Trama; M Urbonas; M Wartenberg; A Weinman Journal: ESMO Open Date: 2021-06-14
Authors: Richard Colling; Andrew Protheroe; Mark Sullivan; Ruth Macpherson; Mark Tuthill; Jacqueline Redgwell; Zoe Traill; Angus Molyneux; Elizabeth Johnson; Niveen Abdullah; Andrea Taibi; Nikki Mercer; Harry R Haynes; Anthony Sackville; Judith Craft; Joao Reis; Gabrielle Rees; Maria Soares; Ian S D Roberts; Darrin Siiankoski; Helen Hemsworth; Derek Roskell; Sharon Roberts-Gant; Kieron White; Jens Rittscher; Jim Davies; Lisa Browning; Clare Verrill Journal: Diagnostics (Basel) Date: 2021-11-25